SystImmune
Redmond, US · Founded 2022 · Delaware corporation
Founders & leadership
YZ
Yi ZhuNamed on SEC filing
JD
Jie D'EliaNamed on SEC filing
Board
HZ
Hai ZhuBoard director
SZ
Suya ZhangBoard director
Reported raises · per SEC filings
Form D private placements$15.1M disclosed across 2 rounds · 2024
▶$7.9MraisedOct 2024 · 2 investors · OtherRule 506(b)
▶$7.9MraisedOct 2024 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Hai ZhuDirector
- Suya ZhangDirector
- Yi ZhuExecutive Officer, Director
- Offering amount
- $7.9M
- Amount sold
- $7.9M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$7.2MraisedJun 2024 · 2 investors · BiotechnologyRule 506(b)
▶$7.2MraisedJun 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yi ZhuExecutive Officer, Director
- Hai ZhuDirector
- Jie D'EliaExecutive Officer
- Suya ZhangDirector
- Offering amount
- $7.2M
- Amount sold
- $7.2M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has SystImmune raised?
- SystImmune has disclosed $15.1M raised across 2 rounds.
- Where is SystImmune headquartered?
- SystImmune is headquartered in Redmond, US.